Modulation by the dorsal, but not the ventral, hippocampus of the expression of behavioural sensitization to amphetamine

International Journal of Neuropsychopharmacology

Volumn 11, Issue 4, 2008, Pages 497-508

  Degoulet, Mickaël ^a,b   Rouillon, Christophe ^b   Rostain, Jean Claude ^a   David, Hélène N ^c   Abraini, Jacques H ^b,c,d  

^a AIX MARSEILLE UNIVERSITY   (France)

^b GIP CYCERON   (France)

^c NNOXe Pharmaceuticals Inc   (Canada)

^d UNIVERSITÉ DE CAEN   (France)

Author keywords

Amphetamine; Behavioural sensitization; Dorsal hippocampus; Lidocaine; Ventral hippocampus

Indexed keywords

AMPHETAMINE; LIDOCAINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CONTROL; BRAIN FUNCTION; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; DRUG INHIBITION; DRUG SENSITIZATION; DRUG USE; ENVIRONMENTAL EXPOSURE; HIPPOCAMPUS; LOCOMOTION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

AMPHETAMINE; ANESTHETICS, LOCAL; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DATA INTERPRETATION, STATISTICAL; HIPPOCAMPUS; LIDOCAINE; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHANNEL BLOCKERS;

EID: 44349105293     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114570700822X     Document Type: Article

References (53)

1. Amaral DG, Witter MP (1995). Hippocampal formation. In: Paxinos G (Ed.), The Rat Nervous System, 2nd edn (pp. 443-493). New York: Academic Press.
2. Anagnostaras SG, Robinson TE (1996). Sensitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning. Behavioral Neuroscience 110, 1397-1414.
3. Anagnostaras SG, Schallert T, Robinson TE (2002). Memory processes governing amphetamine-induced psychomotor sensitization. Neuropsychopharmacology 26, 703-715.
4. Badiani A, Oates MM, Day HE, Watson SJ, Akil H, Robinson TE (1999). Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behavioral Brain Research 103, 203-209.
5. Bannerman DM, Grubb M, Deacon RM, Yee BK, Feldon J, Rawlins JN (2003). Ventral hippocampal lesions affect anxiety but not spatial memory. Behavioral Brain Research 139, 197-213.
6. Bannerman DM, Yee BK, Good MA, Heupel MJ, Iversen SD, Rawlins JM (1999). Double dissociation of function within the hippocampus: a comparison of dorsal, ventral and complete hippocampal cytotoxic lesions. Behavioral Neuroscience 113, 1170-1188.
7. Bardgett ME, Henry JD (1999). Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors. Neuroscience 94, 59-70.
8. Bechara A (2005). Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nature Neuroscience 8, 1458-1463.
9. Brog JS, Salyapongse A, Deutch AY, Zahm DS (1993). The patterns of afferent innervation of the core and the shell in the accumbens part of the rat ventral striatum: immunohistochemical detection of retrogradly transported fluoro-gold. Journal of Comparative Neurology 338, 255-278.
10. Browman KE, Badiani A, Robinson TE (1996). Fimbria-fornix lesions do not block sensitization to the psychomotor activating effects of amphetamine. Pharmacology, Biochemistry and Behavior 53, 899-902.
11. Browman KE, Badiani A, Robinson TE (1998). Modulatory effect of environmental stimuli on the susceptibility to amphetamine sensitization: a dose-effect study in rats. Journal of Pharmacolology and Experimental therapeutics 287, 1007-1014.
12. Burns LH, Robbins TW, Everitt BJ (1993). Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of d-amphetamine. Behavioral Brain Research 55, 167-183.
13. Cador M, Bjijou Y, Stinus L (1995). Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65, 385-395.
14. Caine SB, Humby T, Robbins TW, Everitt BJ (2001). Behavioral effects of psychomotor stimulants in rats with dorsal or ventral subiculum lesions: locomotion, cocaine, self-administration, and prepulse inhibition of startle. Behavioral Neuroscience 115, 880-894.
15. Coutureau E, Galani R, Jarrad LE, Cassel JC (2000). Selective lesions of the entorhinal cortex, the hippocampus or the fimbria-fornix in the rat: a comparison of effects on spontaneous and amphetamine-induced locomotion. Experimental Brain Research 131, 381-392.
16. David HN, Ansseau M, Abraini JH (2005). Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of ' intact' animals. Brain Research Reviews 50, 336-360.
17. David HN, Ansseau M, Lemaire M, Abraini JH (2006). Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine released in a memantine-like fashion and protect against behavioral sensitization. Biological Psychiatry 60, 49-57.
18. Ferbinteanu J, McDonald RJ (2000). Dorsal and ventral hippocampus: same or different? Psychobiology 28, 314-324.
19. Ferbinteanu J, McDonald RJ (2001). Dorsal/ventral hippocampus, fornix, and conditioned place preference. Hippocampus 11, 187-200.
20. Flicker C, Geyer MA (1982). Behavior during hippocampal microinfusions. III. Lidocaine versus picrotoxin. Brain Research 257, 129-136.
21. Groenewegen HJ, Vermeulen-Van der Zee E, te Kortschot A, Witter MP (1987). Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of phaseolus vulgaris leucoagglutinin. Neuroscience 23, 103-120.
22. Jay TM, Glowinski J, Thierry AM (1995). Selectivity of the hippocampal projections to the prelimbic area of the prefrontal cortex in the rat. Brain Research 505, 337-340.
23. Kalivas PW, Stewart J (1991). Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Research Reviews 16, 223-244.
24. Kalivas PW, Weber B (1988). Amphetamine injection into the ventral mesencephalon sensitized rats to peripheral amphetamine and cocaine. Journal of Pharmacology and Experimental Therapeutics 245, 1095-1102.
25. Kantak KM, Black Y, Valencia E, Green-Jordan K, Eichebaum HB (2002). Stimulus-response functions of the lateral dorsal striatum and regulation of behavior studied in cocaine maintenance-cue reinstatement model in rats. Psychopharmacology (Berlin) 161, 278-287.
26. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989). Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Science 45, 599-606.
27. Karler R, Calder LD, Turkanis SA (1991). DNQX blockade of amphetamine behavioral sensitization. Brain Research 552, 295-300.
28. Kelley AE, Domesick VB (1982). The distribution of the projections from the hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseadish peroxidase study. Neuroscience 27, 198-213.
29. Kjelstrup KG, Tuvnes FA, Steffenach HA, Murison R, Moser EI, Moser MB (2002). Reduced fear expression after lesions of the ventral hippocampus. Proceedings of the National Academy of Science USA 99, 10825-10830.
30. Lomber SG (1999). The advantages and limitations of permanent or reversible deactivation techniques in the assessment of neural function. Journal Neuroscience Methods 86, 109-117.
31. Mittleman G, Bratt AM, Chase R (1998). Heterogeneity of the hippocampus: effects of subfield lesions on locomotion elicited by dopaminergic agonist. Behavioural Brain Research 92, 31-45.
32. Moser E, Moser MB, Andersen P (1993). Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. Journal of Neuroscience 13, 3916-3925.
33. O'Brien CP, Childress AR, McLellan AT, Ehrman R (1992). Classical conditioning in drug-dependent humans. Annals of the New York Academy Sciences 654, 400-415.
34. Paulson PE, Robinson TE (1991). Sensitization to systemic amphetamine produces an enhanced locomotor response to a subsequent intra-accumbens amphetamine challenge in rats. Psychopharmacology (Berlin) 104, 140-141.
35. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. New York: Academic Press.
36. Peleg-Rabstein D, Feldon J (2006). Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release. Neuropharmacology 51, 947-957.
37. Pert A, Post R, Weiss SR (1990). Conditioning as a critical determinant of sensitization by psychomotor stimulants. NIDA Reseach Monograph 97, 208-241.
38. Riegert C, Galani R, Heiling S, Lazarus C, Cosquer B, Cassel JC (2004). Electrolytic lesions of the ventral subiculum weakly alter spatial memory but potentiate amphetamine-induced locomotion. Behavioural Brain Research 152, 23-34.
39. Robinson TE, Becker JB (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Research Reviews 11, 157-198.
40. Robinson TE, Berridge KC (1993). The neural basis of drug craving: an incentive-sensitization theory view. Brain Research Reviews 18, 247-291.
41. Rouillon C, Abraini JH, David HN (2007). Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens. Hippocampus 17, 1028-1036.
42. Sarnyai Z (1998). Neurobiology of stress and cocaine addiction. Studies on corticotrophin-releasing factor in rat, monkeys, and humans. Annals of the New York Academy Sciences 851, 371-387.
43. Schaub CL, Schmelzeis MC, Mittleman G (1997). The effects of limbic lesions on locomotion and stereotypy elicited by dopaminergic agonists in the rat. Behavioural Brain Research 84, 129-143.
44. Sellings LH, Clarke PB (2003). Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. Journal of Neuroscience 23, 6295-6303.
45. Siegel S, Castellan Jr. NJ (1988). Nonparametric Statistics for the Behavioral Sciences. New York: McGraw-Hill International Editions (Statistical series).
46. Stewart J, Badiani A (1993). Tolerance and sensitization to the behavioral effects of drugs. Behavioural Pharmacology 4, 289-312.
47. Thierry AM, Gioanni Y, Degenetais E, Glowinski J (2000). Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus 10, 411-419.
48. Wilkinson LS, Mittleman G, Torres E, Humby T, Hall FS, Robbins TW (1993). Enhancement of amphetamineinduced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus. Behavioural Brain Research 55, 143-150.
49. Wolf ME, Dahlin SL, Hu XT, Xue CJ, White K (1995). Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience 69, 417-439.
50. White IM, Whitaker C, White W (2006). Amphetamine-induced hyperlocomotion in rats: hippocampal modulation of the nucleus accumbens. Hippocampus 16, 596-603.
51. White NM (1996). Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction 91, 921-949.
52. Yoshikawa T, Shibuya H, Kaneno S, Toru M (1991). Blockade of behavioral sensitization to metamphetamine by lesion of hippocampal-accumbal pathway. Life Science 48, 1325-1332.
53. Yoshikawa T, Watanabe A, Shibuya H, Toru M (1993). Involvement of the fimbria-fornix in the initiation but not the expression of metamphetamine-induced sensitization. Pharmacology, Biochemistry and Behavior 4, 691-695.